Live Breaking News & Updates on Luiz Carlos Dias

Stay updated with breaking news from Luiz carlos dias. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Brazilian bishop resigns at 62; accused of sexually harassing priests, seminarians | News Headlines

Pope Francis has accepted the resignation of Bishop Valdir Mamede of Catanduva, Brazil. ....

Distrito Federal , Pope Francis , Moacir Silva , Bishop Luiz Carlos Dias , Bishop Mamede , Bishop Valdir Mamede , Diocese Of Catanduva , Catholic World , Archbishop Moacir Silva , Luiz Carlos Dias , Father Mamede , Pope Benedict ,

Matching Sinopharm, fellow China biotech Sinovac sees 78% COVID-19 vaccine efficacy

A little over a week after Sinopharm nabbed the world’s first full approval from Chinese regulators on a 79% efficacy showing for its COVID-19 vax, fellow Chinese native Sinovac, using similar tech, has shown pretty much the same numbers. ....

Luiz Carlos Dias , Jair Bolsonaro , University Of Oxford , University Of Campinas , Clinical Trials Summit , Premier Educational Event Focused , Decentralized Clinical , Wall Street , Lancet Infectious Diseases , Sinovac Biotech , Sino Pharm , Covid 19 , Corona Virus , லூயிஸ் கார்லோஸ் டயஸ் , ஜெயர் போல்சனாரோ , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , பல்கலைக்கழகம் ஆஃப் காம்பினாக்கள் , மருத்துவ சோதனைகள் உச்சிமாநாடு , ப்ரிமியர் கல்வி நிகழ்வு கவனம் , சுவர் தெரு , சினோ பார்ம் , கொரோனா வைரஸ் , தடுப்பு மருந்துகள் ,

Chinese vaccine test results delayed

© Getty Images
Chinese pharmaceutical company Sinovac will reportedly delay releasing the results from its various COVID-19 vaccine trials until January.
Sources told The Wall Street Journal that Sinovac’s vaccine, CoronaVac, had recently reached phase three trials in Brazil, where it had been shown to be more than 50 percent effective at preventing the coronavirus.
However, the Journal reported this week that Sinovac asked the Butantan Institute, the Brazilian research center that has been testing the vaccine, to delay releasing results for another 15 days as it compiles data from other trials in Indonesia and Turkey.
ADVERTISEMENT
“There can’t be three efficacy results for the same vaccine,” said Dimas Covas, Butantan’s director, according to the Journal. According to Covas, the delay has nothing to do with the efficacy of the vaccine, which is expected to be among the first authorized for use in Brazil. ....

Dimas Covas , Luiz Carlos Dias , Butantan Institute , University Of Campinas , Wall Street Journal , Carlos Dias , டைமாஸ் கோவாஸ் , லூயிஸ் கார்லோஸ் டயஸ் , புத்தாண்தான் நிறுவனம் , பல்கலைக்கழகம் ஆஃப் காம்பினாக்கள் , சுவர் தெரு இதழ் , கார்லோஸ் டயஸ் ,

China's Sinovac Delays Covid-19 Vaccine Trial Results

Updated Dec. 23, 2020 5:02 pm ET
SÃO PAULOâChinese firm Sinovac Biotech Ltd. has delayed the announcement of results from late-stage trials of its Covid-19 vaccine to January as it consolidates data from Brazil with test results from Indonesia and Turkey.
Brazil, which is the first country to complete Phase 3 trials of CoronaVac, had been expected to announce the vaccineâs efficacy rate on Wednesday. However, Brazilâs Butantan Institute, the research center backed by SÃ£o Pauloâs state government that has been testing CoronaVac, said Sinovac asked for 15 more days to analyze the data together with results from other trials of the vaccine, which is also being tested in Indonesia and Turkey. ....

Dimas Covas , Luiz Carlos Dias , Brazil Butantan Institute , Sinovac Biotech Ltd , University Of Campinas , Sinovac Biotech , Butantan Institute , டைமாஸ் கோவாஸ் , லூயிஸ் கார்லோஸ் டயஸ் , பிரேசில் புத்தாண்தான் நிறுவனம் , பல்கலைக்கழகம் ஆஃப் காம்பினாக்கள் , புத்தாண்தான் நிறுவனம் ,